Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma. - Wikidata - wikimedia - TriplyDB

Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.

Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.

http://www.wikidata.org/entity/Q35350126

about

Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation.In vivo monitoring of the antiangiogenic effect of neurotensin receptor-mediated radiotherapy by small-animal positron emission tomography: a pilot study.Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer Peptides and peptide hormones for molecular imaging and disease diagnosis Induced overexpression of protein kinase D1 stimulates mitogenic signaling in human pancreatic carcinoma PANC-1 cells Crosstalk between insulin receptor and G protein-coupled receptor signaling systems leads to Ca²+ oscillations in pancreatic cancer PANC-1 cells.Role of protein kinase D signaling in pancreatic cancer Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation.Molecular imaging of gene expression and protein function in vivo with PET and SPECT.Regulatory peptide receptors in human hepatocellular carcinomas.Neurotensin and its receptors in the control of glucose homeostasis.The role of neurotensin in central nervous system pathophysiology: what is the evidence?Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus.Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer.Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors.Radiometallated peptides for molecular imaging and targeted therapy.Rationale for the use of radiolabelled peptides in diagnosis and therapy.Neurotensin, a Novel Messenger to Cross-Link Inflammation and Tumor Invasion via Epithelial-Mesenchymal Transition Pathway.Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia Evaluation of neurotensin receptor 1 as a potential imaging target in pancreatic ductal adenocarcinoma.New Neurotensin analogue radiolabeled by (99m) Technetium as a potential agent for tumor identification.A (99m) Tc-tricine-HYNIC-labeled peptide targeting the neurotensin receptor for single-photon imaging in malignant tumors.Neurotensin receptors in pancreatic ductal carcinomas.Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(IV)-peptide bioconjugates.Gut peptide receptor expression in human pancreatic cancers.Protein kinase C nu/protein kinase D3 nuclear localization, catalytic activation, and intracellular redistribution in response to G protein-coupled receptor agonists.KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.Radiopharmaceuticals for imaging and endoradiotherapy of neurotensin receptor-positive tumors.Structure-Activity Relationship Studies of Amino Acid Substitutions in Radiolabeled Neurotensin Conjugates.Flow-Assisted Synthesis: A Key Fragment of SR 142948A Stereoselective Synthesis of β-(5-Arylthiazolyl) α-Amino Acids and Use in Neurotensin Analogues

P2860

Q24654005-4363BC7F-E04F-4D87-A0B0-C6B33368D167 Q28542653-D16ABB0E-9471-465F-839A-352AFD648819 Q31809911-D6DF7D81-655E-4DE1-98EA-A3432A342FC1 Q33584733-721A867A-8E00-4813-9136-E2BE00D2E6D3 Q33820455-E8D598BA-62E9-4FE5-B75E-55229B81BA38 Q33846924-527D7356-0E87-4E53-AF9C-C096F9729E01 Q33923820-A9A7CD12-394C-481F-A138-B3FB6BCD6602 Q34188673-773A831E-335F-4C37-810B-2420FD517B30 Q34279846-4C229D1B-3C90-40C1-85AF-4C62A1F6FF72 Q34286857-31FC88EC-164E-4129-85DB-725751AA8F53 Q34918519-F9713B14-321F-4182-A85E-FB828F1A43F3 Q35357724-77DA6362-CA89-4BCE-A5A8-1C44FC7B78AA Q36449538-9C70FBF6-B212-47D3-B2C4-DE6BD2F7EDD9 Q36544566-E3B89FF4-11B4-484E-BDD5-3F40C4BFF198 Q37365603-D8A99782-0608-4633-9DE6-87CC5F172BE6 Q37399121-78C86CAE-05C0-4325-BC71-932723213A81 Q37573308-2EE70C6F-2DA5-407F-AB44-5FE2E56B3731 Q37731332-F4AFFB2D-02CA-4CDE-8641-B03C10B3A77A Q37847064-64FD663E-99AF-439F-81A7-F8D44D482C56 Q37990410-44C96E29-465B-4A6F-B3F5-25B005E5C4CF Q38248621-3A53E0F9-01BE-46A5-A976-6470D6BD1987 Q38596500-D911D019-0101-4B94-86F7-43FD9F906ECC Q38680000-8530BDD0-0E5A-49F2-856E-351459E03498 Q38694727-F7236414-D2F5-47B5-8610-AF9AAED49CE2 Q39036960-DA4E08F1-6FC0-4C93-8AAB-8BA905617476 Q39336194-115F5F09-BC80-4C24-AAD8-3CC3197577AE Q39400663-4BE54F50-0C81-499B-89C9-6DE40C6F0756 Q40879057-3FC1E1A8-31B6-4D54-9BDC-1E6AEC79065D Q44391310-2A389F93-C93A-4F71-BB7D-398070D6EBF2 Q46471150-91B18181-542F-4D4D-AB5C-FE00D227A00A Q48346415-044C675C-FED5-440A-B479-BD724EE03337 Q52901225-50489376-E184-4979-9513-087B8F68FDDF Q57816227-68FA892B-F421-442B-BC37-10896AB481D8 Q58099616-E94AADF3-DC8D-45FA-9B4B-EAA20D0050AF

P2860

Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.

http://www.wikidata.org/entity/Q35350126

description

1998 nî lūn-bûn

@nan

1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.

@ast

Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.

@en

type

label

Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.

@ast

Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.

@en

prefLabel

Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.

@ast

Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.

@en

P1433

Q35350126-08F05556-28BF-4894-872E-95657A55693F

P1476

Q35350126-7067A14C-F590-4604-A561-776519208B50

P2093

Q35350126-158263D5-C6F1-4976-8A65-D40D87A263B3

Q35350126-22D31D1D-613E-448E-B89F-6F008A242443

Q35350126-7664B7BD-A63C-41D6-8654-F46E00144A35

Q35350126-A9C388C0-84CF-4F77-8674-15552BE92C79

Q35350126-CCC0A356-282A-4CED-9B02-C5C69C1C0E9D

P2860

Q35350126-3CB85620-C31E-48CA-99A6-CADFA3A06DF1

Q35350126-3F7ED72B-95C3-48DD-B78E-FC1F59D470FD

Q35350126-6FD567A1-6F9F-431B-B538-65AD8EB1AA51

Q35350126-943194C8-4BF0-4295-8B36-0484D4B9E202

Q35350126-9931A080-3CE5-4C05-9F68-D530602A1529

Q35350126-ABF10FBC-2FE1-4636-962D-401AD742ED3F

Q35350126-EBEE0229-80A7-4ADC-BC4E-5CBE3283DA35

P304

Q35350126-74B8B199-8E2F-4C93-825A-128358B92ED5

P31

Q35350126-A6B414A9-0FCA-427E-B193-F071BF20E0AD

P356

Q35350126-E80EFDAF-1A71-46EF-A090-F328FD4F8764

P407

Q35350126-F0328CDE-F3F7-4166-8267-76361FD2093D

P433

Q35350126-73061204-8340-46BE-9C66-4D41BBF01450

P478

Q35350126-728D32DB-F04D-405A-8AA9-2DC9D3727F84

P577

Q35350126-7A6984AE-B245-4749-9357-2D4BC95C453C

P5875

Q35350126-B9C629BE-005D-4A63-9342-F784996F3A53

P698

Q35350126-CBEFBA29-916A-4C0D-ADD0-83505F634DB8

P921

Q35350126-FCFEB20D-48C6-4AA6-84DF-C2C5B187A1B3

P932

Q35350126-82EF0AC0-9B7A-41A9-AD37-0CB4CA035D97

P356

P1433

P1476

Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.

@en

P2093

Büchler M

http://www.w3.org/2001/XMLSchema#string

Friess H

http://www.w3.org/2001/XMLSchema#string

Laissue J

http://www.w3.org/2001/XMLSchema#string

Reubi JC

http://www.w3.org/2001/XMLSchema#string

Waser B

http://www.w3.org/2001/XMLSchema#string

P2860

Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor

Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.

Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging.

Internalization and intracellular mobilization of neurotensin in neuronal cells.

Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.

Distribution of neurotensin binding sites in rat brain: a light microscopic radioautographic study using monoiodo [125I]Tyr3-neurotensin.

Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

P304

546-550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.42.4.546

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

1998-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13668680

http://www.w3.org/2001/XMLSchema#string

P698

9616318

http://www.w3.org/2001/XMLSchema#string

P921

P932

1727058

http://www.w3.org/2001/XMLSchema#string